The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patients’ understanding and adherence to oral anti-cancer medication (OAM): Results of an institutional pilot study.
 
Angie Mae Rodday
Research Funding - Seagen (Inst)
 
Douglas W Hackenyos
No Relationships to Disclose
 
Raisa Masood
No Relationships to Disclose
 
Nicole Savidge
No Relationships to Disclose
 
Mingqian Lin
No Relationships to Disclose
 
Daqin Mao
No Relationships to Disclose
 
Feng Qing Wang
No Relationships to Disclose
 
Rachel Murphy-Banks
No Relationships to Disclose
 
Ruth Ann Weidner
No Relationships to Disclose
 
Rachel J. Buchsbaum
Patents, Royalties, Other Intellectual Property - “Potent Agelastatin Derivatives as Modulators for Cancer Invasion and Metastasis” Provisional patent application: Docket Number: MITX-9505/00US 317239-2690 5/13/2017 application in collaboration with Dr. Mohammad Movassaghi (Inst)
 
John Kalil Erban
Stock and Other Ownership Interests - Merck; Merck (I); Perrigo; Perrigo (I); Prothena; Prothena (I)
Consulting or Advisory Role - Tesaro
Research Funding - Macrogenics (Inst); Tesaro (Inst)
 
Susan K. Parsons
Research Funding - Seagen (Inst)